Cardiol Therapeutics Files US$150M Base Shelf Prospectus (NASDAQ:CRDL)

Cardiol Therapeutics files US$150M base shelf prospectus (NASDAQ:CRDL)

Cardiol Therapeutics (CRDL) files Canada shelf prospectus & U.S. Form F-10 to potentially raise up to $150M.

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission

TORONTO, Ontario — September 10, 2026 — Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a late-stage life sciences company advancing anti-inflammatory and anti-fibrotic therapies for heart [...]